American Oncology Network, Inc. (AONC)
USD 4.49
(2.28%)
USD 4.49
(2.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 1.27 Billion | 1.14 Billion | 943.74 Million | 724.74 Million |
| Cost of Revenue | 1.21 Billion | 1.05 Billion | 865.78 Million | 658.63 Million |
| Gross Profit | 66.05 Million | 95.45 Million | 77.95 Million | 66.1 Million |
| Operating Expenses | 83.97 Million | 89.88 Million | 77.04 Million | 44.03 Million |
| Selling, General and Administrative Expenses | 100.71 Million | 89.88 Million | 77.04 Million | 44.03 Million |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | 31.23 Million | 289 Thousand | 736 Thousand | 180 Thousand |
| Cost and Expenses | 1.32 Billion | 1.14 Billion | 942.83 Million | 702.67 Million |
| Operating Income | -49.15 Million | 5.56 Million | 911 Thousand | 22.07 Million |
| Interest Expense | 6.41 Million | 3.41 Million | 1.41 Million | 1.11 Million |
| Income Tax Expense | 384 Thousand | 1.02 Billion | 460 Thousand | -783 Thousand |
| Earnings before Tax | -62.5 Million | 2.58 Million | 355 Thousand | 21.16 Million |
| Net Income | -5.54 Million | 2.58 Million | -105 Thousand | 21.95 Million |
| Earnings Per Share Basic | -1.36 | 0.27 | -0.00 | 0.74 |
| Earnings Per Share Diluted | -1.36 | 0.27 | -0.00 | 0.74 |
| Weighted Average Shares Outstanding | 6.68 Million | 9.53 Million | 41.68 Million | 29.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.68 Million | 9.53 Million | 41.68 Million | 29.86 Million |
| Gross Margin | 0.05 | 0.08 | 0.08 | 0.09 |
| EBIT Margin | -0.03 | 0.02 | 0.01 | 0.04 |
| Profit Margin | -0.00 | 0.00 | -0.00 | 0.03 |
| EBITDA | -39.35 Million | 23.08 Million | 7.85 Million | 25.94 Million |
| Earnings Before Tax Margin | -0.04 | 0.00 | 0.00 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 433.98 Million | 364.33 Million | 1.27 Billion | 324.18 Million | 336.3 Million | 314.96 Million |
| Cost of Revenue | 404.58 Million | 354.94 Million | 1.19 Billion | 315.56 Million | 310.89 Million | 291.39 Million |
| Gross Profit | 29.39 Million | 9.39 Million | 82.79 Million | 8.62 Million | 25.41 Million | 23.56 Million |
| Operating Expenses | 37.4 Million | 28.27 Million | 100.71 Million | 27.88 Million | 25.19 Million | 1.49 Million |
| Selling, General and Administrative Expenses | 36.73 Million | 28.27 Million | - | 27.88 Million | 25.19 Million | 1.49 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 664 Thousand | -1.9 Million | 114 Thousand | 7.8 Million | -3.3 Million | -4.84 Million |
| Cost and Expenses | 441.99 Million | 383.22 Million | 1.29 Billion | 343.44 Million | 336.09 Million | 1.49 Million |
| Operating Income | -8 Million | -19.23 Million | -49.15 Million | -20.61 Million | -24.39 Million | -1.49 Million |
| Interest Expense | -1.83 Million | 1.76 Million | 6.41 Million | 1.91 Million | 1.53 Million | 1.55 Million |
| Income Tax Expense | -324 Thousand | 2.89 Million | 384 Thousand | 69 Thousand | 315 Thousand | 35.15 Thousand |
| Earnings before Tax | 1.06 Million | -22.11 Million | -62.5 Million | -22.27 Million | -28.85 Million | -1.67 Million |
| Net Income | 1.39 Million | -7.84 Million | -5.54 Million | -3.75 Million | -1.79 Million | -1.71 Million |
| Earnings Per Share Basic | 0.12 | -1.04 | - | -0.56 | -0.27 | -0.17 |
| Earnings Per Share Diluted | 0.12 | -1.04 | - | -0.56 | -0.27 | -0.17 |
| Weighted Average Shares Outstanding | 11.58 Million | 7.52 Million | 6.68 Million | 6.68 Million | 6.61 Million | 10.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.58 Million | 7.52 Million | 6.68 Million | 6.68 Million | 6.61 Million | 10.18 Million |
| Gross Margin | 0.07 | 0.03 | 0.06 | 0.03 | 0.08 | 0.07 |
| EBIT Margin | -0.02 | -0.04 | - | -0.02 | -0.01 | -0.00 |
| Profit Margin | 0.00 | -0.02 | -0.00 | -0.01 | -0.01 | -0.01 |
| EBITDA | -8 Million | -15.45 Million | - | -6.45 Million | -2.72 Million | -1.49 Million |
| Earnings Before Tax Margin | -0.02 | -0.05 | -0.04 | -0.06 | -0.07 | -0.00 |
000850
002515
ABT
002187
603344
DRRX